Fumi Kawakami

Prof. Dr. Fumi Kawakami

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Sekino YoheiSekino Yohei
Sekino Yohei
NSNaoya Sakamoto
Naoya Sakamoto
KGKeisuke Goto
Keisuke Goto
RHRirino Honma
Ririno Honma
YSYoshinori Shigematsu
Yoshinori Shigematsu
WYWataru Yasui
Wataru Yasui
The transcribed ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs that are absolutely conserved across species and are involved in carcinogenesis in some cancers. However, the expression and biological role of T-UCRs in renal cell carcinoma (RCC) remain poorly understood. This study aimed to examine the expression and functional role of Uc.416 + A and analyze the association between Uc.416 + A and epithelial-to-mesenchymal transition in RCC. Expression of Uc.416 + A in 35 RCC tissues, corresponding normal kidney tissues and 13 types of normal tissue samples was determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). We performed a cell growth and migration assay in RCC cell line 786-O transfected with negative control and siRNA for Uc.416 + A. We evaluated the relation between Uc.416 + A and miR-153, which has a complimentary site of Uc.416 + A. qRT-PCR analysis revealed that the expression of Uc.416 + A was higher in RCC tissues than that in corresponding normal kidney tissues. Inhibition of Uc.416 + A reduced cell growth and cell migration activity. There was an inverse correlation between Uc.416 + A and miR-153. Western blot analysis showed Uc.416 + A modulated E-cadherin, vimentin and snail. The expression of Uc.416 + A was positively associated with the expression of SNAI1, VIM and inversely associated with the expression of CDH1. The expression of Uc.416 + A was upregulated in RCC and especially in RCC tissues with sarcomatoid change. Uc.416 + A promoted epithelial-to-mesenchymal transition through miR-153. These results suggest that Uc.416 + A may be a promising therapeutic target.

20 July 2020 in Pathology International
Verified
Journal Article
Closed access
PDF file
FKFumi Kawakami
Fumi Kawakami
TNToshitaka Nagao
Toshitaka Nagao
YHYumi Honda
Yumi Honda
JSJunki Sakata
Junki Sakata
RYRyoji Yoshida
Ryoji Yoshida
YMYoshiki Mikami
Yoshiki Mikami

1 January 2023 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
SKShiho Kuji
Shiho Kuji
AEAkira Endo
Akira Endo
MKManabu Kubota
Manabu Kubota
AUAtsushi Uekawa
Atsushi Uekawa
FKFumi Kawakami
Fumi Kawakami
NSNao Suzuki
Nao Suzuki
Kuji S, et al. J Gynecol Oncol. 2022 Oct;34(1):e1. https://doi.org/10.3802/jgo.2023.34.e1

27 September 2021 in International Journal of Gynecological Pathology
Verified
Journal Article
Closed access
TKTatsuya C.T. Katafuchi
Tatsuya C.T. Katafuchi
FKFumi Kawakami
Fumi Kawakami
YIYutaka M.D. Iwagoi
Yutaka M.D. Iwagoi
FSFumitaka M.D. Saito
Fumitaka M.D. Saito
YMYoshiki Mikami
Yoshiki Mikami
In the fifth edition of the World Health Organization classification of female genital tumors, neuroendocrine neoplasms are subcategorized as neuroendocrine tumors (NETs) of grade 1 (G1) and G2, and neuroendocrine carcinoma. NET G3 is not included, as it is for classification of pancreas tumors. Herein, we report 2 cases of “NET G3” of the uterine cervix with long-term follow-up. The patients are 40- and 36-yr-old women who presented with polypoid masses on the uterine cervix. Microscopic examination of hysterectomy specimens revealed tumor features similar to those of pancreatic NET G3 and intestinal type mucinous carcinoma cells invading the cervical stroma. In both cases, the NET component was positive for synaptophysin and chromogranin A, and negative for TTF-1. Mitotic counts were <1/2 mm2 and 5/2 mm2, and the Ki-67 labeling indexes were 57% and 39%, respectively. Pathologic stage classifications (AJCC, version 9) were pT1b1, pN0, and cM0 (FIGO stage IB1), and both patients received adjuvant therapy. One patient had lung and pancreas metastases 4 to 8 yr after initial surgery, which were surgically removed. Both patients remain alive without evidence of recurrent disease 6 and 16 yr after initial surgery. The indolent clinical courses of these cases appear to indicate that cervical “NET G3” is biologically closer to NET than neuroendocrine carcinoma; thus, including uterine cervical “NET G3” in the classification may be justified. However, the optimal management for this tumor type remains undetermined.

29 January 2024 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Open access
PDF file
FKFumi Kawakami
Fumi Kawakami
HYHiroyuki Yanai
Hiroyuki Yanai
NTNorihiro Teramoto
Norihiro Teramoto
YMYu Miyama
Yu Miyama
MYMasanori Yasuda
Masanori Yasuda
YMYoshiki Mikami
Yoshiki Mikami
Context.—: Endocervical adenocarcinoma is divided into human papillomavirus (HPV)-associated (HPVA) and HPV-independent (HPVI) in the 5th edition of the World Health Organization (WHO) tumor classification launched in 2020. However, the validity of the morphologic criteria used for biopsy specimens in real-world practice remains undetermined. Objective.—: To validate the utility of the 5th edition of the WHO classification for biopsy samples, focusing on its diagnostic criteria with the aid of ancillary studies. Design.—: We retrieved 217 cases of endocervical adenocarcinoma from 6 institutions, in which glass slides of both biopsy and resection specimens were available for review. Concordance between the biopsy and resection specimen diagnoses was evaluated. For discordant diagnoses, an algorithmic approach with ancillary studies proposed by the international group was applied to confirm their utility to improve the accuracy of biopsy diagnosis. Results.—: The biopsy diagnosis matched the resection specimen diagnosis in 197 cases (concordance rate, 91%; κ = 0.75). The concordance rate was significantly higher for HPVA than HPVI (95% versus 81%, P = .001). There were no significant differences in the proportions of HPVA and HPVI or the accuracy of biopsy diagnosis between the participating institutions. All 19 discordant cases with unstained glass slides available were accurately recategorized as HPVA or HPVI using HPV in situ hybridization; p16 immunohistochemistry was positive in 3 of 9 cases of gastric-type HPVI that were negative by in situ hybridization. Conclusions.—: The 5th edition of the WHO criteria for biopsy diagnosis of endocervical adenocarcinoma distinguishes HPVA from HPVI well when ancillary studies are adequately applied.

6 September 2023 in Pathology International
Verified
Journal Article
Closed access
FKFumi Kawakami
Fumi Kawakami
KYKen Yamaguchi
Ken Yamaguchi
SMSachiko Minamiguchi
Sachiko Minamiguchi
TSTamotsu Sudo
Tamotsu Sudo
THTakanori Hirose
Takanori Hirose
YMYoshiki Mikami
Yoshiki Mikami